<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-05-23">May 23, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Magnus</forename><forename type="middle">F</forename><surname>Kaffarnik</surname></persName>
							<email>magnus.kaffarnik@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Navid</forename><surname>Ahmadi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johan</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of General</orgName>
								<orgName type="institution">University Hospital of Wuerzburg</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Visceral-, Vascular-and Paediatric Surgery</orgName>
								<address>
									<settlement>Wuerzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tilo</forename><surname>Wuensch</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johann</forename><surname>Pratschke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Stockmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maciej</forename><surname>Malinowski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of General</orgName>
								<orgName type="institution" key="instit1">University Hospital of Homburg</orgName>
								<orgName type="institution" key="instit2">Visceral-, Vascular-and Paediatric Surgery</orgName>
								<address>
									<settlement>Homburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MS.</roleName><forename type="first">N</forename><forename type="middle">A</forename><surname>Tw</surname></persName>
						</author>
						<author>
							<persName><roleName>MS.</roleName><forename type="first">N</forename><forename type="middle">A</forename><surname>Jfl</surname></persName>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution">Azienda Ospedaliero Universitaria Careggi</orgName>
								<address>
									<country key="IT">ITALY</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">Charite ´-University Hospital</orgName>
								<address>
									<country>Berlin. B.R.A.H</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-05-23">May 23, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">1A285F102DFBE1D15611BCE8D75B0876</idno>
					<idno type="DOI">10.1371/journal.pone.0178237</idno>
					<note type="submission">Received: July 12, 2016 Accepted: April 28, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:11+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>MS NA MFK</term>
					<term>Methodology: MFK MM MS JP</term>
					<term>Software: TW</term>
					<term>Supervision: MM JP MS</term>
					<term>Validation: JFL JP</term>
					<term>Visualization: MFK MM</term>
					<term>Writing -original draft: MFK</term>
					<term>Writing -review &amp; editing: MM JP MS</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>To investigate the relationship between the degree of liver dysfunction, quantified by maximal liver function capacity (LiMAx test) and endothelin-1, TNF-α and IL-6 in septic surgical patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>28 septic patients (8 female, 20 male, age range 35-80y) were prospectively investigated on a surgical intensive care unit.</s><s>Liver function, defined by LiMAx test, and measurements of plasma levels of endothelin-1, TNF-α and IL-6 were carried out within the first 24 hours after onset of septic symptoms, followed by day 2, 5 and 10.</s><s>Patients were divided into 2 groups (group A: LiMAx !100 μg/kg/h, moderate liver dysfunction; group B: LiMAx &lt;100 μg/kg/h, severe liver dysfunction) for analysis and investigated regarding the correlation between endothelin-1 and the severity of liver failure, quantified by LiMAx test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Group B showed significant higher results for endothelin-1 than patients in group A (P = 0.01, d5; 0.02, d10).</s><s>For TNF-α, group B revealed higher results than group A, with a significant difference on day 10 (P = 0.005).</s><s>IL-6 showed a non-significant trend to higher results in group B. The Spearman's rank correlation coefficient revealed a significant correlation between LiMAx and endothelin-1 (-0.434;</s><s>P &lt;0.001), TNF-α (-0.515;</s><s>P &lt;0.001) and IL-6 (-0.590;</s><s>P &lt;0.001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>Sepsis-related hepatic dysfunction is associated with elevated plasma levels of endothelin-1, TNF-α and IL-6.</s><s>Low LiMAx results combined with increased endothelin-1 and TNF-α and</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The liver is a key organ in the pathophysiological response to bacterial endotoxin in sepsis.</s><s>Patients with septic shock develop liver failure in up to 50% of the cases and liver failure indicates poor outcome in critically ill patients <ref type="bibr" target="#b2">[1,</ref><ref type="bibr" target="#b3">2]</ref>.</s><s>Septic shock is accompanied by increased plasma endothelin-1 (ET-1) levels.</s><s>Activation of ET-1, a proinflammatory cytokine, is associated with enhanced leukocyte trafficking, cytokine production, monocyte stimulation and profound hemodynamic changes complicating septic shock <ref type="bibr" target="#b4">[3,</ref><ref type="bibr" target="#b5">4]</ref>.</s><s>Particularly the regulation of liver perfusion during sepsis largely depends on ET-1-receptor activity.</s><s>Experimental data indicate that bacterial endotoxin exposure leads to elevation of liver ET-1 due to release of tumor necrosis factor (TNF-α) and other inflammatory cytokines by Kupffer cells.</s><s>These mediators bind to receptors on liver endothelial cells and cause increased liberation of ET-1.</s><s>Elevated ET-1 provokes a strong sinusoidal vasoconstriction, which may lead to a microcirculatory impairment of liver parenchyma with heterogeneous perfusion, focal hypoxia and, finally to hepatic failure <ref type="bibr" target="#b6">[5]</ref><ref type="bibr" target="#b7">[6]</ref><ref type="bibr" target="#b8">[7]</ref><ref type="bibr" target="#b9">[8]</ref>.</s></p><p><s>The reliable detection of ET-1 is limited by its instability and short plasma half-life of 1-2 minutes.</s><s>Hence, an immunoluminometric assay for measurement of the c-terminal ET-1 precursor fragment (CT-proET-1) was developed.</s><s>CT-proET-1 correlates well with the release of the active ET-1 and can be used to indirectly measure the release of ET-1 in physiological and pathological conditions <ref type="bibr" target="#b10">[9,</ref><ref type="bibr" target="#b11">10]</ref>.</s></p><p><s>Determining the severity of liver dysfunction is still a challenge due to low specificity of liver function tests <ref type="bibr" target="#b12">[11]</ref>.</s><s>Previous studies have shown that the Maximal Liver Function Capacity (LiMAx test) provides a reliable non-invasive diagnostic tool for determining the enzymatic liver function in different clinical settings <ref type="bibr" target="#b13">[12]</ref><ref type="bibr" target="#b14">[13]</ref><ref type="bibr" target="#b15">[14]</ref><ref type="bibr" target="#b16">[15]</ref>.</s></p><p><s>The LiMAx test is based on the selective enzymatic demethylation of intravenously administered 13 C-labeled methacetin by cytochrome P450 1A2 in hepatocellular cells.</s><s>Our recently published data demonstrated the LiMAx test as an adequate diagnostic tool to detect early liver dysfunction in sepsis with high specificity and sensitivity <ref type="bibr" target="#b17">[16]</ref>.</s></p><p><s>The aim of this study is to investigate prospectively plasma levels of CT-proET-1, TNF-α and Interleukin-6 (IL-6) in relation to the severity of septic liver failure, measured by LiMAx test.</s><s>The study also focuses on establishing the correlation between LiMAx test and proinflammatory cytokines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>For this study, we collected and evaluated plasma samples from a patient collective of 28 septic patients admitted to the surgical intensive care unit (SICU) of the Charite ´, University Hospital, Berlin, Germany.</s><s>The patients are the same septic patients we investigated recently for the evaluation of the LiMAx test in sepsis <ref type="bibr" target="#b17">[16]</ref>.</s><s>Patients were recruited and probes were sampled between October 2011 and February 2013.</s><s>Detailed characteristics of the study population, the study design, sepsis therapy, determination of baseline parameter and parameter over the study period have been reported previously <ref type="bibr" target="#b17">[16]</ref>.</s><s>Briefly, inclusion criterion was new onset of bacterial sepsis (less than 24h) according to the 2003 International Sepsis Definitions Conference <ref type="bibr" target="#b18">[17]</ref>.</s><s>All patients also met the new criteria for sepsis according to the Third International The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s><s>Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) <ref type="bibr" target="#b19">[18]</ref>.</s><s>Exclusion criteria were preexisting liver diseases (e. g. cirrhosis, fibrosis, hepatitis) and liver surgery in the last 6 months.</s><s>After inclusion, LiMAx test and blood samples collection for the measurement of CT-proET-1, TNF-α and IL-6 plasma levels were performed at baseline (&lt;24h after onset of sepsis) and on 2 nd , 5 th , and 10 th days.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests:</head><p><s>The aim of the study was to establish a correlation of CT-proET-1, TNF-α and IL-6 values with the severity of liver failure, measured by LiMAx test.</s><s>For this the patient population was divided into two groups: (A) Moderate liver dysfunction (LiMAx !100 μg/kg/h, n = 17) and (B) severe liver dysfunction (LiMAx &lt;100 μg/kg/h, n = 11).</s><s>In addition the relationship between LiMAx test, CT-proET-1, TNF-α and IL-6 was investigated.</s></p><p><s>The study was approved by the Ethics Review Board of the Charite ´Medical Faculty in accordance with the provisions of the Helsinki Declaration.</s><s>Written informed consent was obtained from all participants or their responsible relatives prior to their participation in the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurements of CT-proET-1, TNF-α and IL-6</head><p><s>In each patient, serial blood samples were drawn using an indwelling arterial catheter into EDTA tubes (EDTA-Monovette, Sarstedt, Nuernberg, Germany).</s><s>All blood samples were centrifuged according to the requirement of the detection kit and the supernatant was frozen in aliquots at -80˚C immediately.</s><s>CT-proET-1, TNF-α and IL-6 were batch measured after completing the last patient.</s></p><p><s>Plasma CT-proET-1 levels were analyzed by a fully automated sandwich immunoassay (CT-proET-1 KRYPTOR TM , B.R.A.H.M.S., Hennigsdorf, Germany) <ref type="bibr" target="#b10">[9]</ref>.</s><s>For the analysis of TNF-α and IL-6 solid phase ELISA immunoassays were performed according to the instructions of the manufacturer (Quantikine human TNF-α immunoassay and Quantikine human IL-6 immunoassay, R&amp;D systems, Inc, Minneapolis, USA).</s><s>Routine laboratory parameters were measured according to the standards of the laboratory institute of the Charite ´-University Hospital Berlin.</s><s>Normal ranges were defined for procalcitonin &lt;0.5 μg/l, C-reactive protein &lt;5 mg/l, white blood count 3.9-10.5</s><s>/nl, total bilirubin &lt;1.2 mg/dl and INR 0.9-1.25 respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LiMAx test</head><p><s>The LiMAx test was performed using the FLIP TM Analyzer (Humedics GmbH, Berlin, Germany).</s><s>A bolus of 2 mg/kg body weight 13 C-labelled methacetin was given intravenously and exhaled breath was continuously analyzed.</s><s>Prior to substrate injection, the baseline ratio of 13 CO 2 / 12 CO 2 concentration was recorded in the native exhaled air.</s><s>After metabolising in the liver, the proportion of exhaled 13 C-labelled CO 2 and physiological 12 C CO 2 (delta over base) was measured online over a period of 60 min maximum and the LiMAx value was calculated following the previously described formula <ref type="bibr" target="#b16">[15]</ref>.</s><s>In mechanical ventilated patients a special adapter was used to dissipate the exhaled gas to the 13 CO 2 -detector.</s><s>If patients were on continuous haemodialysis, the injection of 13 C-methacetin was performed after interrupting the blood pump for 60 minutes to avoid recirculation and altered kinetics.</s><s>Results are given in μg/ kg/h, and the normal range is &gt;315 μg/kg/h.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>All statistical analyses were performed using a statistical software package SPSS 19.0 of (Chicago, IL, USA).</s><s>Data are presented as median value with inter-quartile range illustrated with box-and-whisker plots for non-normally distributed data.</s><s>Outliers are plotted as separate dots.</s></p><p><s>Individual time points were compared using repeated measures analysis of variance.</s><s>Group differences were compared by the appropriate tests according to scale and data distribution, including the Mann-Whitney-U-Test and the independent t test.</s><s>Correlations between quantitative variables were tested using Spearman's rank correlation coefficient for ordinal data.</s><s>Statistical significance was considered at P &lt;0.05 and P &lt;0.0125 respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Progression of liver function, endothelin-1 and cytokines in sepsis</head><p><s>Twenty-eight patients admitted to the SICU who met the inclusion criteria of sepsis, were enrolled for this study.</s><s>The clinical characteristics for study inclusion are shown in Table <ref type="table" target="#tab_1">1</ref>.</s></p><p><s>LiMAx results have been reported recently in detail <ref type="bibr" target="#b17">[16]</ref>.</s><s>For better illustration we show specific LiMAx data again.</s><s>In septic patients, mean baseline LiMAx values on day 0 were below normal range (208 ± 131 μg/kg/h), dropping until day 2 (165 ± 93 μg/kg/h; n. s.) and significantly increasing on day 5 (289 ± 190 μg/kg/h; P = 0.004) until day 10 (357 ± 179 μg/kg/h; P = 0.009; Fig <ref type="figure" target="#fig_0">1A</ref>).</s><s>Mean plasma levels of CT-proET-1 in septic patients were above the normal range (&lt;74 pmol/l) with highest values on day 0 (247 ± 143 pmol/l), stepwise decreasing on day 2 (233 ± 144 pmol/l; n. s.) and day 5 (167 ± 90 pmol/l; P = 0.001) until day 10 (143 ± 86 pmol/l; n. s.; Fig <ref type="figure" target="#fig_0">1B</ref>).</s><s>Mean plasma levels of TNF-α were above the normal range (0.5-2.8 pg/ ml) whilst the whole course of sepsis with a peak at day 0 (11 ± 5 pg/ml), followed by a decrease on day 2 (8 ± 5 pg/ml; P = 0.001) and day 5 (6 ± 3 pg/ml; P = 0.007), proceeding constantly until day 10 (6 ± 5 pg/ml; n. s.; Fig <ref type="figure" target="#fig_0">1C</ref>).</s><s>The IL-6 serum levels were above the normal range Progression of liver function, CT-proET-1 and cytokines according to the severity of liver dysfunction</s></p><p><s>Group B showed a higher severity of illness than group A expressed in significantly higher APACHE II (34.54 ± 9 vs. 21.31</s><s>± 8.6, P = 0.002) and SOFA scores (14.54 ± 3.8 vs. 9 ± 4.1, P = 0.003).</s><s>Static liver function tests also revealed higher values in patients with severe liver dysfunction (group B vs. group A: bilirubin 3.98 ± 2.9 vs. 1.64 ± 2.6, P = 0.011; INR 1.87 ± 0.3 vs. 1.58 ± 0.2, P = 0.02, Table <ref type="table" target="#tab_2">2</ref>).</s><s>CT-proET-1 baseline values on day 0 did not differ in both study groups (group A: 239 ± 96 pmol/l; group B: 259 ± 199 pmol/l).</s><s>From day 2, patients of group A showed lower values for CT-proET-1 than patients of group B. The peak of CT-proET-1 levels in group B was revealed on day 2 (264 ± 156 pmol/l), followed by a continuous decrease until day 10 (188 ± 106 pmol/l), whereas CT-proET-1 levels in group A showed the highest level on day 0 (239 ± 96 pmol/l), dropping down continuously until day 10 (116 ± 60 pmol/l).</s><s>Statistical significant differences appeared on days 5 and 10 (P = 0.01 day 5; P = 0.02 day 10).</s><s>Values of both groups remained above the cut off up to day 10 (Fig <ref type="figure" target="#fig_1">2A</ref>).</s><s>Patients of group A revealed lower TNF-α values than patients of group B. Group A showed the highest levels for TNF-α on day 0 (10 ± 6 pg/ml) with a continuous decrease until day 10 (5 pg/ml ± 4).</s><s>The peak in group B appeared on day 0 (13 ± 5 pg/ml), followed by a decrease until day 5 (6 ± 3 pg/ml) and another increase on day 10 (8 ± 5 pg/ml).</s><s>Values on day 10 showed a statistical significant difference (P = 0.005 day 10).</s><s>Values of both groups remained above the cut off (Fig <ref type="figure" target="#fig_1">2B</ref>).</s></p><p><s>The distribution of IL-6 demonstrated a non-significant trend to higher values in patients of group B. The highest values revealed on day 0 for both groups (group A: 332 ± 153 pg/ml, group B: 403 ± 127 pg/ml).</s><s>Whereas the data of group A decreased continuously until day 10 (62 ± 61 pg/ml), values of group B showed another increase on day 10 (188 ± 171 pg/ml).</s><s>Values of both groups remained above the cut off up to day <ref type="bibr">10 (Fig 2C)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Correlation between CT-pro-ET-1, TNF-α, IL-6 and liver dysfunction</head><p><s>The Spearman's rank correlation test showed a statistically significant negative correlation between CT-pro-ET-1 and impaired liver function on days 2, 5 and 10 with Spearman's rank correlation coefficients of -0.441 (day 2 + 5; P = 0.019) and -0.503 (day 10; P = 0.012).</s><s>Values of TNF-α revealed a statistically significant negative correlation with the liver dysfunction on days 2 and 10 as indicated by Spearman's coefficient of -0.537 (d2; P = 0.003) and -0.460 (d10; P = 0.027).</s><s>The correlation between IL-6 serum level and liver dysfunction was statistically</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The presented prospective observational cohort study investigated the correlation between septic liver failure, the vasoactive peptide ET-1 and the proinflammatory cytokines TNF-α and IL-6 in a clinical setting.</s><s>The study design, covering a period of 10 days after onset of sepsis, provided more detailed information about dynamics of the progression of the peptides as described in previous studies <ref type="bibr" target="#b20">[19]</ref><ref type="bibr" target="#b21">[20]</ref><ref type="bibr" target="#b22">[21]</ref>.</s><s>In addition to the promising results of the dynamic LiMAx test for the assessment of liver dysfunction in sepsis <ref type="bibr" target="#b17">[16]</ref>, the study shows a correlation between proinflammatory cytokines and the quantified enzymatic liver function for the first time.</s></p><p><s>The main finding of the study is the correlation between elevated CT-pro-ET-1 levels and low LiMAx values.</s><s>Moreover, the negative correlation between LiMAx, CT-pro-ET-1 and TNF-α suggests an interaction between liver failure and these peptides, which leads to the conclusion that ET-1 and TNF-α may have an important impact on the development of liver failure in sepsis.</s><s>These findings are in agreement with the results of Brauner and colleagues, who described elevated ET-1 levels in septic patients during a 24 hours course of data collection with higher values in non-survivors <ref type="bibr" target="#b20">[19]</ref>.</s><s>The inverse correlation between ET-1 and LiMAx is not strong (r = 0.434) but significant (P &lt; 0.001), similar to the correlation between TNF-α and LiMAx (r = 0.515 and 0.59, P &lt; 0.001).</s><s>However, the correlation between quantitative liver function and ET-1 confirms the findings that elevated ET-1 might be one reason for decreased liver function.</s><s>These findings are in accordance with previous studies reporting a pivotal impact of ET-1 in development of organ failure in sepsis due to a reduction of splanchnic, renal and pulmonary blood flow <ref type="bibr" target="#b23">[22,</ref><ref type="bibr" target="#b24">23]</ref>.</s></p><p><s>Experimental data indicate that regulation of sinusoidal liver perfusion strongly depends on ET-1 during sepsis <ref type="bibr" target="#b25">[24,</ref><ref type="bibr" target="#b26">25]</ref>.</s><s>Iwai and colleagues described a remarkable liver enzyme leakage after infusion of ET-1 in combination with endotoxin in rats.</s><s>The authors concluded that ET-1 have an important role in the development of experimental liver injury related with endotoxemia and cytokine production <ref type="bibr" target="#b27">[26]</ref>.</s><s>Our results confirm these findings in a clinical setting with humans demonstrating a reasonable correlation between ET-1 and LiMAx results and significant higher ET-1 levels in patients with severe reduction of liver function.</s><s>In addition, the simultaneous increase of TNF-α leads to the conclusion that there is an interaction between ET-1 and TNF-α in development of septic liver failure.</s><s>These findings are in concert with other authors, describing the release of ET-1 by increased levels of TNF-α, resulting in a strong sinusoidal vasoconstriction with concomitant liver cell damage deteriorating liver dysfunction <ref type="bibr" target="#b5">[4,</ref><ref type="bibr" target="#b25">24,</ref><ref type="bibr" target="#b28">27]</ref>.</s></p><p><s>Several studies investigated sinusoidal vasodilatators in different settings of liver dysfunction.</s><s>Demirci and colleagues came to the conclusion that ET-1 blocker delays onset of liver injury in diabetic rats <ref type="bibr" target="#b29">[28]</ref>.</s><s>Bahde and co-workers found decreased hepatic ischemia-related events after application of Endothelin blockers in liver transplanted rats.</s><s>They came to the conclusion that Endothelin blockade improve the cell engraftment and liver repopulation <ref type="bibr" target="#b30">[29,</ref><ref type="bibr" target="#b31">30]</ref>.</s><s>Oki and colleagues described in an animal model an up-regulation of vascular endothelial growth factor by dual blockade of Endothelin <ref type="bibr" target="#b32">[31]</ref>.</s><s>In concert with these findings, the correlation between ET-1 and quantitative liver dysfunction, described in the presented study, implicates that enhancement of sinusoidal blood flow may improve liver dysfunction in septic patients.</s><s>Further experimental and clinical studies should focus that issue.</s></p><p><s>The impact of ET-1 on organ failure in severe sepsis was investigated before <ref type="bibr" target="#b23">[22,</ref><ref type="bibr" target="#b24">23]</ref>.</s><s>The correlation between ET-1 and quantitative liver failure has not been previously reported.</s><s>Using the LiMAx test as a dynamic diagnostic tool for quantification of liver function, the results emerging from the presented study show a correlation between the degree of liver Endothelin-1 in septic liver failure, measured by LiMAx test dysfunction and ET-1.</s><s>Interestingly, differences in ET-1 levels in patients with severe (group B; LiMAx &lt;100 μg/kg/h) and moderate (group A; LiMAx !100 μg/kg/h) liver dysfunction are significant in the later course of sepsis.</s><s>This observation cannot be answered systematically based on solid experimental or clinical data as more studies are required for analyzing ET-1 for a longer period of time.</s><s>In contrast, Tschaikowsky and co-workers found higher big-ET plasma concentrations, a precursor peptide of ET-1, in non-surviving septic patients in the later course of sepsis.</s><s>After initial declining, big-ET levels rose again and were significantly higher on day 28 in non-survivors compared to survivors.</s><s>They came to the conclusion that the second rise may be the result of ET-induced factors of an ongoing septic process <ref type="bibr" target="#b24">[23]</ref>.</s><s>In the presented study ET-1 did not show a second rise during the study period of 10 days.</s><s>But the second increase of TNF-α and IL-6 on day 10 in patients with severe liver dysfunction (group B) confirms this hypothesis.</s><s>Because TNF-α works as an activator for ET-1 release, ET-1 may increase concomitantly, but only after day 10.</s></p><p><s>The present study has some important limitations.</s><s>First, samples were taken from relatively small number of patients from a single institution.</s><s>A larger series of patients in a multicenter trial is required to undertake further analysis.</s><s>Second, the patient population was divided in only two investigation groups.</s><s>Patients with moderate liver dysfunction content a variety of LiMAx results from normal range (!315μg/kg/h) as well as reduced liver function (!100-314μg/kg/h).</s><s>To properly differentiate between different levels of hepatic dysfunction and combined ET-1 levels, larger patient groups with a more detailed clinical characterization of hepatic failure are needed.</s><s>Third, due to the complex interactions of pro-and anti-inflammatory mediators, it is most likely that the relationship between ET-1, TNF-α and liver dysfunction is only one possible pathway for the development of liver failure in sepsis.</s><s>In addition, we showed LiMAx results twice after publication recently (Fig <ref type="figure" target="#fig_0">1A</ref>) <ref type="bibr" target="#b17">[16]</ref>.</s><s>This procedure was essential for better understanding the correlation of the investigated parameter.</s><s>Nonetheless, our results support the interdependence of ET-1 and TNF-α and the possible impact of these peptides on liver dysfunction in sepsis and the results of the study may contribute to a better understanding of the role of ET-1 in septic liver failure and the potential clinical impact.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>In summary, this study focused on the relationship between septic liver dysfunction and proinflammatory peptides in sepsis.</s><s>The results show a correlation between ET-1 and an impaired liver function, quantified by the LiMAx test, in critically ill patients.</s><s>The findings approve the close interaction between TNF-α and ET-1 in sepsis.</s><s>However, a larger sample size of patients and a larger number of cytokines would be needed to address the question of influence on septic liver failure and may strengthen the findings of this preliminary report.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting information</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Endothelin- 1</head><label>1</label><figDesc><div><p><s>in septic liver failure, measured by LiMAx test PLOS ONE | https://doi.org/10.1371/journal.pone.0178237</s><s>May 23, 2017 2 / 13</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Progression of CT-proET-1 and cytokines by severity of liver dysfunction in sepsis.</s><s>(A) CT-proET-1, (B) TNF-α, (C) IL-6.</s><s>White box: group A; LiMAx !100μg/kg/h; Shaded box: group B; LiMAx &lt;100μg/kg/h.</s><s>Bold lines, medians; box plots, 25th to 75th percentiles.</s><s>Horizontal broken lines indicate the normal range.</s><s>Outliers are illustrated as circles.</s><s>https://doi.org/10.1371/journal.pone.0178237.g002</s></p></div></figDesc><graphic coords="7,39.57,146.27,536.32,535.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Relationship between liver function and cytokines in septic patients using Spearman's rank correlation coefficient.</s><s>(A) LiMAx vs. CT-proET-1, (B) LiMAx vs. TNF-a, (C) LiMAx vs. IL-6.</s><s>https://doi.org/10.1371/journal.pone.0178237.g003</s></p></div></figDesc><graphic coords="9,39.57,145.42,536.32,536.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>S1Fig.</head><label></label><figDesc><div><p><s>Progression of LiMAx, CT-proET-1, TNF-α and IL-6 by severity of sepsis defined by APACHE-II-score.</s><s>(DOCX) S2 Fig. Progression of CT-proET-1, TNF-α und IL-6 by patient outcome (Patients survived and ICU LOS &lt;30days vs. patients deceased or ICU LOS !30days).</s><s>(DOCX) S1 Table.</s><s>Serum concentration of CT-proET-1 [pmol/l], TNF-α [pg/ml] und Il-6 [pg/ml] in patienten with LiMAx &lt;100μg/kg/h and ! 100 μg/kg/h.</s><s>(DOCX) S2 Table.</s><s>Progression of LiMAx, CT-proET-1, TNF-α and IL-6 by severity of sepsis defined by APACHE-II-score.</s><s>(DOCX) S3 Table.</s><s>Progression of CT-proET-1, TNF-α und IL-6 by patient outcome.</s><s>(DOCX) S4 Table.</s><s>Correlation between CT-proET-1, TNFα, IL-6 and liver dysfunction.</s><s>(DOCX)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="5,39.57,78.01,536.32,535.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>This does not alter our adherence to PLOS ONE policies on sharing data and materials.</s><s>Martin Stockmann is the inventor of the LiMAx test and has capital interest in Humedics, the company marketing the LiMAx test.</s><s>This does not alter our adherence to PLOS ONE policies on sharing data and materials.</s><s>All other authors declare no financial or non-financial competing interests potentially interfering with the submitted research article.</s><s>No funds were obtained for payment of the authors.</s></p></div></figDesc><table /><note><p><s>The study was funded by research grants of the Charite ´-University Hospital, Berlin.</s><s>B.R.A.H.M.S. GmbH (Hennigsdorf, Germany) supported this study by provision of CT-proET-1 assay kits (BRAHMS CRproET1 Kryptor, Material Transfer Agreement).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 . Clinical characteristics.</head><label>1</label><figDesc></figDesc><table><row><cell>Number of patients</cell><cell>28</cell></row><row><cell>Age (years)</cell><cell>67 ± 10 (36-80)</cell></row><row><cell>Gender (m/w)</cell><cell>20/8</cell></row><row><cell>Septic focus</cell><cell></cell></row><row><cell>Abdomen</cell><cell>15</cell></row><row><cell>Lung</cell><cell>9</cell></row><row><cell>Other</cell><cell>4</cell></row><row><cell>Severity of sepsis</cell><cell></cell></row><row><cell>Sepsis</cell><cell>2</cell></row><row><cell>Severe sepsis</cell><cell>2</cell></row><row><cell>Septic shock</cell><cell>24</cell></row><row><cell>APACHE-II-score  †</cell><cell>26 ± 11 (10-49)</cell></row><row><cell>SOFA score  †</cell><cell>9 ± 5 (0-18)</cell></row><row><cell>SAPS-II score  †</cell><cell>52 ± 19 (18-90)</cell></row><row><cell>Procalcitonin (μg/l)  †</cell><cell>23 ± 26 (1-75)</cell></row><row><cell>C-reactive protein (mg/l)  †</cell><cell>162 ± 84 (40-330)</cell></row><row><cell>WBC (/nl)  †</cell><cell>15 ± 14 (1-47)</cell></row><row><cell>Bilirubin (mg/dl)  †</cell><cell>1 ± 1 (0,2-3,7)</cell></row><row><cell>INR  †</cell><cell>1.5 ± 0.3 (1-2)</cell></row><row><cell>labMELD score</cell><cell>18 ± 6 (8-31)</cell></row><row><cell cols="2">Data are presented as mean ± standard deviation (range). APACHE, Acute Physiology and Chronic Health</cell></row></table><note><p><s>Evaluation; SOFA, Sequential Organ Failure Assessment; SAPS, Simplified Acute Physiology Score; WBC: white blood cell count; INR International Normalised Ratio.</s><s>† Data collected on day 0. https://doi.org/10.1371/journal.pone.0178237.t001</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 . Clinical characteristics and severity of illness in the study groups.</head><label>2</label><figDesc></figDesc><table><row><cell></cell><cell>Group A</cell><cell>Group</cell><cell></cell></row><row><cell></cell><cell>LiMAx !100μg/kg/h</cell><cell>LiMAx &lt;100μg/kg/h</cell><cell></cell></row><row><cell></cell><cell>n = 17</cell><cell>n = 11</cell><cell></cell></row><row><cell>Age (years)</cell><cell>68.58 ± 11.4 (36-87)</cell><cell>64.78 ± 8.7 (51-77)</cell><cell>n. s.</cell></row><row><cell>APACHE-II-score  †</cell><cell>21.31 ± 8.6 (10-40)</cell><cell>34.54 ± 9 (18-49)</cell><cell>P = 0.002</cell></row><row><cell>SOFA score  ‡</cell><cell>9 ± 4.1 (1-17)</cell><cell>14.54 ± 3.8 (7-21)</cell><cell>P = 0.003</cell></row><row><cell>SAPS-II score  ‡</cell><cell>54.23 ± 17.2 (27-85)</cell><cell>70.18 ± 21.7 (40-95)</cell><cell>n. s.</cell></row><row><cell>Procalcitonin (μg/l)  ‡</cell><cell>28.84 ± 27.4 (1-82)</cell><cell>24.47 ± 25.6 (1-73)</cell><cell>n. s.</cell></row><row><cell>C-reactive protein (mg/l)  ‡</cell><cell>231.74 ± 74.6 (68-349)</cell><cell>230.91 ± 68.3 (124-340)</cell><cell>n. s.</cell></row><row><cell>WBC (/nl)  ‡</cell><cell>18.33 ± 5.7 (8-29)</cell><cell>33.80 ± 12.9 (16-55)</cell><cell>P = 0.001</cell></row><row><cell>Bilirubin (mg/dl)  ‡</cell><cell>1.64 ± 2.6 (0.3-11)</cell><cell>3.98 ± 2.9 (0.4-19)</cell><cell>P = 0.011</cell></row><row><cell>INR  ‡</cell><cell>1.58 ± 0.2 (1.2-2.1)</cell><cell>1.87 ± 0.3 (1.4-2.4)</cell><cell>P = 0.020</cell></row><row><cell>labMELD score</cell><cell>16 ± 5 (27-8)</cell><cell>21 ± 7 (31-11)</cell><cell>n. s.</cell></row><row><cell>Mortality n (%)</cell><cell>0 (0)</cell><cell>6 (55)</cell><cell>P&lt;0.001</cell></row></table><note><p><s>Data are presented as mean ± standard deviation (range).</s><s>APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; SAPS, Simplified Acute Physiology Score; WBC: white blood cell count; INR International Normalised Ratio.</s><s>† Day 0.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | https://doi.org/10.1371/journal.pone.0178237May 23, 2017  </note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">‡ Highest value during study course. https://doi.org/10.1371/journal.pone.0178237.t002 Endothelin-1 in septic liver failure, measured by LiMAx test PLOS ONE | https://doi.org/10.1371/journal.pone.0178237 May 23, 2017</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The study was funded by research grants of the Charite ´-University Hospital, Berlin.</s><s>B.R.A.H. M.S. GmbH, (Hennigsdorf, Germany) supported this study by provision of CT-proET-1 assay kits (BRAHMS CRproET1 Kryptor, Material Transfer Agreement).</s><s>This does not alter our adherence to PLOS ONE policies on sharing data and materials.</s><s>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s></p><p><s>The authors would like to thank the team of the Surgical Intensive Care Unit of the Charite for supporting the study.</s><s>We would also like to thank the team of the "workgroup for the liver" for their valuable comments on planning and designing the study.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Fig 1. Progression of liver function, CT-proET-1 and cytokines in septic patients. (A) Maximal liver function capacity (LiMAx), (B) CT-proET-1, (C) TNF-α, (D) IL-6. Bold lines: medians; box plots: 25th to 75th percentiles. Horizontal broken lines indicate the normal range. Outliers are illustrated as circles</title>
		<idno type="DOI">10.1371/journal.pone.0178237.g001</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0178237.g001" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">Endothelin-1 in septic liver failure, measured by LiMAx test</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Jaundice in critical illness: promoting factors of a concealed reality</title>
		<author>
			<persName><forename type="first">N</forename><surname>Brienza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dalfino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cinnella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Diele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bruno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fiore</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00134-005-0023-3</idno>
		<idno type="PMID">16450099</idno>
		<ptr target="https://doi.org/10.1007/s00134-005-0023-3" />
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="267" to="274" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Hepatic dysfunction increases length of stay and risk of death after injury</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Harbrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Zenati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Doyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcmichael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Clancy</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.TA.0000023161.76991.D1</idno>
		<idno type="PMID">12352490</idno>
		<ptr target="https://doi.org/10.1097/01.TA.0000023161.76991.D1" />
	</analytic>
	<monogr>
		<title level="j">J Trauma</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="517" to="523" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Endothelin-1 and its role in the pathogenesis of infectious diseases</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Tanowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Desruisseaux</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lfs.2014.04.021</idno>
		<idno type="PMID">24780317</idno>
		<ptr target="https://doi.org/10.1016/j.lfs.2014.04.021" />
	</analytic>
	<monogr>
		<title level="j">Life Sci</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="110" to="119" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The endothelin system in septic and endotoxin shock</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wanecek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Weitzberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rudehill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldner</surname></persName>
		</author>
		<idno type="PMID">11050285</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">407</biblScope>
			<biblScope unit="page" from="1" to="15" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Chu</surname></persName>
		</author>
		<idno type="DOI">10.1053/jhep.2001.23079</idno>
		<idno type="PMID">11283844</idno>
		<ptr target="https://doi.org/10.1053/jhep.2001.23079" />
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="816" to="820" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Regulation of endothelin synthesis in hepatic endothelial cells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Eakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Olson</surname></persName>
		</author>
		<idno type="PMID">9696707</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="G1068" to="1076" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Endotoxemia Induces IkappaBbeta/NF-kappaB-Dependent Endothelin-1 Expression in Hepatic Macrophages</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gossling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bugarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Rancourt</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1501017</idno>
		<idno type="PMID">26342031</idno>
		<ptr target="https://doi.org/10.4049/jimmunol.1501017" />
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="3866" to="3879" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">TNF-alpha induces interleukin-8 and endothelin-1 expression in human endothelial cells with different redox pathways</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Z</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2004.12.109</idno>
		<idno type="PMID">15652492</idno>
		<ptr target="https://doi.org/10.1016/j.bbrc.2004.12.109" />
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="page" from="985" to="992" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Papassotiriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Morgenthaler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Struck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bergmann</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2005.065581</idno>
		<idno type="PMID">16627560</idno>
		<ptr target="https://doi.org/10.1373/clinchem.2005.065581" />
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1144" to="1151" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Proteolytic processing pattern of the endothelin-1 precursor in vivo</title>
		<author>
			<persName><forename type="first">J</forename><surname>Struck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Morgenthaler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bergmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.peptides.2005.05.010</idno>
		<idno type="PMID">15978702</idno>
		<ptr target="https://doi.org/10.1016/j.peptides.2005.05.010" />
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2482" to="2486" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Gastrointestinal disorders of the critically ill</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Strassburg</surname></persName>
		</author>
		<idno type="PMID">12763502</idno>
	</analytic>
	<monogr>
		<title level="j">Shock liver. Best Pract Res Clin Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="369" to="381" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Schwabauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Videv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pratschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Malinowski</surname></persName>
		</author>
		<idno type="DOI">10.1002/lt.21973</idno>
		<idno type="PMID">20104485</idno>
		<ptr target="https://doi.org/10.1002/lt.21973" />
	</analytic>
	<monogr>
		<title level="j">Liver Transpl</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="172" to="180" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stockmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Malinowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Niehues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Seehofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Neuhaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">HPB (Oxford)</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="139" to="146" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">How to define initial poor graft function after liver transplantation?-a new functional definition by the LiMAx test</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stockmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Malinowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Seehofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Puhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pratschke</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1432-2277.2010.01089.x</idno>
		<idno type="PMID">20444241</idno>
		<ptr target="https://doi.org/10.1111/j.1432-2277.2010.01089.x" />
	</analytic>
	<monogr>
		<title level="j">Transpl Int</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1023" to="1032" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stockmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Riecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Heyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fricke</surname></persName>
		</author>
		<idno type="DOI">10.1097/SLA.0b013e3181ad85b5</idno>
		<idno type="PMID">19561474</idno>
		<ptr target="https://doi.org/10.1097/SLA.0b013e3181ad85b5" />
	</analytic>
	<monogr>
		<title level="j">Ann Surg</title>
		<imprint>
			<biblScope unit="volume">250</biblScope>
			<biblScope unit="page" from="119" to="125" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Early diagnosis of sepsisrelated hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Kaffarnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Vetter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ahmadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lojewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Malinowski</surname></persName>
		</author>
		<idno type="DOI">10.1186/cc13089</idno>
		<idno type="PMID">24172237</idno>
		<ptr target="https://doi.org/10.1186/cc13089" />
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">R259</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Fink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abraham</forename><forename type="middle">E</forename><surname>Angus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1097/01.CCM.0000050454.01978.3B</idno>
		<idno type="PMID">12682500</idno>
		<ptr target="https://doi.org/10.1097/01.CCM.0000050454.01978.3B" />
	</analytic>
	<monogr>
		<title level="m">SCCM/ESICM/ACCP/ATS/ SIS International Sepsis Definitions Conference</title>
				<imprint>
			<date type="published" when="2001">2001. 2003</date>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1250" to="1256" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Deutschman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Seymour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shankar-Hari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Annane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2016.0287</idno>
		<idno type="PMID">26903338</idno>
		<ptr target="https://doi.org/10.1001/jama.2016.0287" />
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="page" from="801" to="810" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Brauner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Clausell</surname></persName>
		</author>
		<idno type="PMID">10823387</idno>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="305" to="313" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">TNF-alpha depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Quinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Iizuka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Monte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Durao</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cyto.2014.10.024</idno>
		<idno type="PMID">25461406</idno>
		<ptr target="https://doi.org/10.1016/j.cyto.2014.10.024" />
	</analytic>
	<monogr>
		<title level="j">Cytokine</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="255" to="260" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia</title>
		<author>
			<persName><forename type="first">P</forename><surname>Schuetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stolz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Morgenthaler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Struck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mueller</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2334-8-22</idno>
		<idno type="PMID">18304365</idno>
		<ptr target="https://doi.org/10.1186/1471-2334-8-22" />
	</analytic>
	<monogr>
		<title level="j">BMC Infect Dis</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">22</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Plasma endothelin-1 levels in septic patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Piechota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Banach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Irzmanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Barylski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piechota-Urbanska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kowalski</surname></persName>
		</author>
		<idno type="DOI">10.1177/0885066607301444</idno>
		<idno type="PMID">17722367</idno>
		<ptr target="https://doi.org/10.1177/0885066607301444" />
	</analytic>
	<monogr>
		<title level="j">J Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="232" to="239" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tschaikowsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lehnert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kaul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ritter</surname></persName>
		</author>
		<idno type="PMID">10890632</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1854" to="1860" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Endothelin-1 aggravates hepatic ischemia/reperfusion injury during obstructive cholestasis in bile duct ligated mice</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshidome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ohtsuka</surname></persName>
		</author>
		<idno type="PMID">20552721</idno>
	</analytic>
	<monogr>
		<title level="j">J Surg Res</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="46" to="53" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Hydrogen sulfide differentially affects the hepatic vasculature in response to phenylephrine and endothelin 1 during endotoxemia</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Norris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Larion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Culberson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Clemens</surname></persName>
		</author>
		<idno type="DOI">10.1097/SHK.0b013e3182736688</idno>
		<idno type="PMID">23143058</idno>
		<ptr target="https://doi.org/10.1097/SHK.0b013e3182736688" />
	</analytic>
	<monogr>
		<title level="j">Shock</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="168" to="175" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Endothelin 1 aggravates acute liver injury in perfused livers of rats after treatment with D-galactosamine</title>
		<author>
			<persName><forename type="first">M</forename><surname>Iwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimazu</surname></persName>
		</author>
		<idno type="DOI">10.1002/hep.510280230</idno>
		<idno type="PMID">9696017</idno>
		<ptr target="https://doi.org/10.1002/hep.510280230" />
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="503" to="509" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines</title>
		<author>
			<persName><forename type="first">B</forename><surname>Battistini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Forget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Laight</surname></persName>
		</author>
		<idno type="PMID">8696980</idno>
	</analytic>
	<monogr>
		<title level="j">Shock</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="167" to="183" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition</title>
		<author>
			<persName><forename type="first">E</forename><surname>Demirci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ferah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gundogdu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ozkanlar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Baygutalp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bayir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Res (Stuttg)</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="272" to="280" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Endothelin-1 receptor A blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bahde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kapoor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Viswanathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Spiegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gupta</surname></persName>
		</author>
		<idno type="DOI">10.1002/hep.26766</idno>
		<idno type="PMID">24114775</idno>
		<ptr target="https://doi.org/10.1002/hep.26766" />
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1107" to="1117" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bahde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kapoor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Bhargava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Palestro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gupta</surname></persName>
		</author>
		<idno type="DOI">10.1002/hep.26005</idno>
		<idno type="PMID">22899584</idno>
		<ptr target="https://doi.org/10.1002/hep.26005" />
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="320" to="330" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Dual blockade of endothelin action exacerbates up-regulated VEGF angiogenic signaling in the heart of lipopolysaccharide-induced endotoxemic rat model</title>
		<author>
			<persName><forename type="first">M</forename><surname>Oki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jesmin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Mowa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Khatun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shimojo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lfs.2014.02.008</idno>
		<idno type="PMID">24548632</idno>
		<ptr target="https://doi.org/10.1016/j.lfs.2014.02.008" />
	</analytic>
	<monogr>
		<title level="j">Life Sci</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="364" to="369" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
